Authorisations of human medicines

Within the framework of the authorisation procedure, Swissmedic assesses the quality, safety and effectiveness of the medicinal product in question on the basis of the comprehensive scientific documentation that is submitted.

If the criteria for authorisation are fulfilled, Swissmedic grants the marketing authorisation, specifies the method of sale (on prescription only/dispensing point) and approves the information for healthcare professionals and the patient information.

Informations

Show all

15.10.2024

Changes to the guidance documents Fast-track authorisation procedure and Temporary authorisation for human medicinal products

Optimisation of the application procedure for the implementation of a fast-track authorisation procedure and the implementation of temporary authorisation

01.10.2024

The “Public Summary SwissPAR” is now called the “Summary report on authorisation”

Swissmedic is changing the name of the “Public Summary SwissPAR” to the “Summary report on authorisation”